Skip to content
Clinical Trials – home
NorwayBack to Norway

Clinical trials in Skedsmokorset – page 17

607 clinical trials in Skedsmokorset, Norway. Every trial is listed in the EU Clinical Trials Register and updated daily.

NorwayOur site in NorwayKliniske-Studier.no(opens in a new tab)
Skedsmokorset at a glance
607
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

607 trials in Skedsmokorset

Open in trial search

Study on the Effectiveness of Volrustomig in Women with High-Risk Locally Advanced Cervical Cancer After Chemoradiation Therapy

Registered drug
Countries:NorwayNorway
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Infliximab
  • Sponsor:AstraZeneca AB

Neck pain

Recruiting

Study on Chiropractic Therapy and Ibuprofen for Acute Neck Pain in Adults

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years
  • Substances:Ibuprofen
  • Sponsor:Akershus University Hospital

Study on Azacitidine for Patients with Myelodysplastic Syndrome After Stem Cell Transplantation

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Karolinska University Hospital

Study Comparing MK-5684 with Abiraterone Acetate or Enzalutamide for Patients with Advanced Prostate Cancer After Hormonal Therapy and Chemotherapy

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone Acetate
  • Sponsor:Merck Sharp & Dohme LLC

Study on Dexamfetamine for Adults with Amphetamine and Opioid Dependence Undergoing Opioid Treatment

Investigational
Countries:NorwayNorway
  • Participants:18–64 years
  • Substances:Dexamfetamine Sulfate
  • Sponsor:Helse Bergen HF

Pulmonary embolism+7

Recruiting

Study on Rosuvastatin for Reducing Blood Clots in Patients with Deep Vein Thrombosis or Pulmonary Embolism

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Rosuvastatin Calcium
  • Sponsor:Centre Hospitalier Regional Et Universitaire De Brest

Neoplasm

Recruiting

Study of Zenocutuzumab for Patients with Solid Tumors with NRG1 Fusion

InvestigationalNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Zenocutuzumab
  • Sponsor:Partner Therapeutics Inc.

Glioblastoma

Recruiting

Study on Lomustine and Temozolomide for Newly Diagnosed Glioblastoma Patients

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Temozolomide
  • Sponsor:Region Oestergoetland

Study on Lymphoblastic Lymphoma Treatment in Children and Adolescents Using Dexamethasone, Prednisone, and PEG-Asparaginase

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:0–17 years
  • Substances:Cyclophosphamide
  • Sponsor:Universitaetsklinikum Muenster AöR

Continued Access Study for Patients with Severe Hemophilia A Using Efanesoctocog Alfa

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Efanesoctocog Alfa
  • Sponsor:Swedish Orphan Biovitrum AB (publ)

Study Comparing Chemotherapy with Irinotecan, Folinic Acid, and Oxaliplatin for Patients with Locally Recurrent Rectal Cancer

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Catharina Ziekenhuis Stichting

Study on the Safety and Effectiveness of TransCon CNP for Infants with Achondroplasia

Investigational
Countries:NorwayNorway
  • Participants:0–17 years
  • Substances:Navepegritide
  • Sponsor:Ascendis Pharma Growth Disorders A/S

Other cities in Norway

The busiest research cities in the country

All 53 cities in Norway

Clinical research in Skedsmokorset

What the registry says about research in the country

01 Cardiovascular Research

Innovative clinical trials focusing on lipoprotein management and prevention of major cardiovascular events in patients with established cardiovascular disease.

  • Cardiovascular Disease Prevention
  • Lipid Management
  • Cardiovascular Event Reduction

Studies evaluating novel therapeutic approaches for reducing cardiovascular mortality and improving patient outcomes.

02 Stroke Prevention

Research examining new treatments for preventing stroke and systemic embolism in patients with atrial fibrillation, comparing innovative therapies with established medications.

  • Atrial Fibrillation Management
  • Anticoagulation Therapy
  • Stroke Risk Reduction

Trials focused on developing safer and more effective treatments for stroke prevention.

03 Vascular Disease Research

Studies investigating treatments for atherosclerotic cardiovascular disease, with emphasis on preventing major adverse cardiovascular events.

  • ASCVD Management
  • Cardiovascular Risk Reduction
  • LDL cholesterol Control

Evaluation of novel therapies targeting established vascular disease and its complications.

04 Pulmonary Medicine

Clinical research examining the effectiveness of combination therapies for Chronic Obstructive Pulmonary Disease, focusing on cardiopulmonary outcomes.

  • COPD Treatment
  • Respiratory Medicine
  • Bronchodilator Therapy

Investigation of advanced treatment options for improving respiratory function and quality of life.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.